Impact of perioperative chemotherapy on survival outcomes among patients with metastatic colorectal cancer to the liver - Supplementary figures

  

Supplementary figure A. Median overall survival in the whole cohort according to the treatment modality after propensity score matching.

  

Supplementary figure B. Overall survival according to the treatment modality after excluding patients with 90-day mortality of most definitive primary site surgery after propensity score matching.

  

Supplementary figure C. Median overall survival comparison between single agent and multiagent chemotherapy after propensity score matching.

  

Supplementary figure D. Median overall survival comparison between adjuvant and neoadjuvant chemotherapy after propensity score matching.

  

Supplementary figure E. Median overall survival according to the treatment modality in (A) MSI-H and (B) MSI-L.

  

Supplementary figure F. Median overall survival comparison between single agent and multiagent chemotherapy in (A) MSI-H and (B) MSI-L.

  

Supplementary figure G. Median overall survival comparison between adjuvant and neoadjuvant chemotherapy in (A) MSI-H and (B) MSI-L.